|
|
|
51-200 employees
View all
|
|
biotechnology
|
|
35 CambridgePark Dr,Cambridge,Massachusetts,US
|
|
About Codiak BioSciencesCodiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics, a new class of medicines with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need. By leveraging the biology of exosomes as natural intercellular transfer mechanisms, Codiak has developed its proprietary engEx Platform to expand upon the innate properties of exosomes to design, engineer and manufacture novel exosome therapeutic candidates. Codiak has utilized its engEx Platform to generate a deep pipeline of engineered exosomes aimed at treating a broad range of disease areas, spanning oncology, neuro-oncology, neurology, neuromuscular disease and infectious disease.
|
Codiak BioSciences Email Formats | Example Email Formats | Percentage |
---|---|---|
{first}.{last} | [email protected] |
100%
|
The widely used Codiak BioSciences email format is {first}.{last} (e.g. [email protected]) with 100% adoption across the company.
To contact Codiak BioSciences customer service number in your country click here to find.
Douglas Williams is the CEO of Codiak BioSciences. To contact Douglas Williams email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.